RE:RE:Pfizer in court over Chinese stealing trade secrets"In its original lawsuit, Pfizer accused Zhong and Qiu of setting up Regor while still working at Pfizer and “stealing the hard work of Pfizer’s scientists and clinicians for their own profit and gain.” Pfizer claimed Regor pinched information from a confidential presentation on its GLP-1 program for diabetes and obesity to help build out the biotech and secure patents."
The complaint alleged that Qiu and Zhong misappropriated trade secrets in violation of the Defend Trade Secrets Act as well as Connecticut trade secret laws. Qiu served as executive director of structural biology at Pfizer-Connecticut, where he led as many as 60 scientists through drug discovery efforts. His group contributed to 29 clinical candidates. Qiu also served on expert review panels for the National Institutes of Health.
Zhong spent 19 years in Pfizer’s R&D organization, most recently as director of pharmacokinetics, dynamics and metabolism (PDM) and head of its external research solutions group, according to the complaint. In that role, he was responsible for business development for Pfizer’s worldwide R&D external research portfolios as well as scientific/compliance oversight for the PDM group’s regulatory submissions.